170 related articles for article (PubMed ID: 4348844)
1. 'Hallucinogenic drugs and central transmitter substances'.
Leonard BE
Int J Neurosci; 1972 Jul; 4(1):35-43. PubMed ID: 4348844
[No Abstract] [Full Text] [Related]
2. The effects of some hallucinogenic drugs upon the metabolism of noradrenaline.
Leonard BE; Tonge SR
Life Sci; 1969 Aug; 8(15):815-25. PubMed ID: 5807314
[No Abstract] [Full Text] [Related]
3. The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain.
Tonge SR; Leonard BE
Life Sci; 1969 Aug; 8(15):805-14. PubMed ID: 5807313
[No Abstract] [Full Text] [Related]
4. [Pharmacological action spectra of hallucinogens].
Waser PG
Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):39-57. PubMed ID: 5141141
[No Abstract] [Full Text] [Related]
5. The hallucinogens and the inhalants.
Cohen S
Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of tritiated 5-hydroxytryptamine in brain slices.
Ross SB; Renyl AL
Life Sci; 1967 Jul; 6(13):1407-15. PubMed ID: 4382451
[No Abstract] [Full Text] [Related]
7. The pharmacology of hallucinogens.
Brawley P; Duffield JC
Pharmacol Rev; 1972 Mar; 24(1):31-66. PubMed ID: 4626282
[No Abstract] [Full Text] [Related]
8. Neurological aspects of hallucinogenic drugs.
Logan WJ
Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
[No Abstract] [Full Text] [Related]
9. The effect of some hallucinogenic drugs on the amino acid precursors of brain monoamines.
Tonge SR; Leonard BE
Life Sci I; 1970 Dec; 9(23):1327-35. PubMed ID: 5493000
[No Abstract] [Full Text] [Related]
10. [RESEARCH CONCERNING THE PHARMACOLOGIC CHARACTERIZATION AND DIFFERENTIATION OF HALLUCINOGENIC DRUGS (INDOLE DERIVATES AND MESCALINE, NALORPHINE, CENTRAL ANTICHOLINERGIC AGENTS, PHENCYCLIDINE)].
JACOB J; LAFILLE C; LOISEAU G; ECHINARD-GARIN P; BARTHELEMY C
Encephale; 1964; 53():520-35. PubMed ID: 14222727
[No Abstract] [Full Text] [Related]
11. A relationship between the hallucinogenic activity of drugs and their electronic configuration.
Snyder SH; Merril CR
Proc Natl Acad Sci U S A; 1965 Jul; 54(1):258-66. PubMed ID: 5216361
[No Abstract] [Full Text] [Related]
12. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
Tonge SR; Leonard BE
Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
[No Abstract] [Full Text] [Related]
13. Psychotomimetic drugs: biochemistry and pharmacology.
Brimblecombe RW
Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
[No Abstract] [Full Text] [Related]
14. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
Snyder SH; Faillace L; Hollister L
Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952
[TBL] [Abstract][Full Text] [Related]
15. Hallucinogenic drugs and circadian rhythms.
Davies JA; Ancill RJ; Redfern PH
Prog Brain Res; 1972; 36():79-95. PubMed ID: 4644034
[No Abstract] [Full Text] [Related]
16. A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.
Stolk JM; Barchas JD; Goldstein M; Boggan W; Freedman DX
J Pharmacol Exp Ther; 1974 Apr; 189(1):42-50. PubMed ID: 4823298
[No Abstract] [Full Text] [Related]
17. The mechanism of action of hallucinogenic drugs on a possible serotonin receptor in the brain.
Smythies JR; Benington F; Morin RD
Int Rev Neurobiol; 1970; 12():207-33. PubMed ID: 4918144
[No Abstract] [Full Text] [Related]
18. Discriminable stimuli produced by hallucinogens.
Kuhn DM; White FJ; Appel JB
Psychopharmacol Commun; 1976; 2(4):345-8. PubMed ID: 996285
[No Abstract] [Full Text] [Related]
19. Letter: The activation of pineal hydroxyindole-O-methyltransferase by psychotomimetic drugs.
Hartley R; Smith JA
J Pharm Pharmacol; 1973 Sep; 25(9):751-2. PubMed ID: 4148515
[No Abstract] [Full Text] [Related]
20. Biogenic amines and psychiatry.
Aust N Z J Psychiatry; 1971 Mar; 5(1):4-9. PubMed ID: 4946453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
